In March 2017,Tempus, which was founded by Eric Lefkofsky, announced that it wanted to partner with the University of Chicago to gather the latest data on breast cancer treatment. The latest data analysis program is designed to provide individual molecular analysis and sequencing in order to be able to come up with individual treatment plans for breast cancer patients. Tempus’ intention is to analyze data taken from 1,000 patients in order to help improve the program not only for the present time but for decades to come in the future as well and more information click here.
At the present time, Tempus uses genomic sequencing and machine learning in order to make timely personal treatment plans. However, the University of Chicago has stated that there is currently not enough easily accessible data for those who are currently battling breast cancer or have done so in years past. The latest analysis program, if it passes the trial stage will be able to provide this.
Eric Lefkofsky is currently the CEO and a co-founder of Tempus. Tempus is a technology organization that specializes in assisting in the treatment of cancer. He has also founded several other organizations, which include Groupon, LightBank, Uptake Technologies, Mediaocean, InnerWorkings and Echo Global Logistics. That being said, there is almost no limit to what sort of field that Lefkofsky will invest in and learn more about Eric Lefkofsky.
Aside from the data technology, funding and logistics organizations mentioned above, Lefkosky, along with his wife, founded the Lefkofsky Family Foundation in 2006. The Foundation is involved with any organization that helps to improve life. This includes but is not limited to Aspen Art Museum, Robert F. Kennedy Human Rights, and The Success Project. Lefkofsky is also an adjunct professor at the University of Chicago and serves as a Trustee of several organizations, including Lurie Children’s Hospital of Chicago, World Business of Chicago and Chicago’s Steppenwolf Theatre Company.